In agreement, population-based studies have shown that during chronic inflammatory diseases such as periodontitis, pulmonary tuberculosis, and cystic fibrosis, hypomethylation of the TLR2 promoter leads to enhanced expression of TLR233,34,46. Here, TLR2 is linked to pulmonary tuberculosis.